1. ARONSON, J. K.; FERNER, R. E. Biomarkers-A general review. et al [Current protocols in pharmacology], v. 76, n. 1, p. 9.23.1-9.23.17, 2017.
2. BOERRIGTER, E. et al. Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration-resistant prostate cancer undergoing first-line abiraterone acetate and prednisone treatment. Molecular oncology, v. 15, n. 9, p. 2453–2465, 2021.
3. DE CASSIA ROSA DE JESUS, J.; ROCHA OLIVEIRA, C. J. Marcadores moleculares tumorais. Revista Brasileira de Ciências Biomédicas, v. 1, n. 1, p. 43, 2020.
4. FEIZY, A. et al. HER2 expression status and prognostic, diagnostic, and demographic properties of patients with gastric cancer: A single center cohort study from Iran. Asian Pacific journal of cancer prevention: APJCP, v. 19, n. 6, p. 1721–1725, 2018.
5. GOODWIN, P. J. et al. Cancer antigen 15-3/mucin 1 levels in CCTG MA.32: A breast cancer randomized trial of metformin vs placebo. JNCI cancer spectrum, v. 5, n. 5, p. kab066, 2021.